Murphy D E, Snowhill E W, Williams M
Research Department, CIBA-GEIGY Corporation, Summit, NJ 07901.
Neurochem Res. 1987 Sep;12(9):775-81. doi: 10.1007/BF00971514.
The binding of [3H]AMPA (DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid), a ligand for the putative quisqualate excitatory amino acid receptor subtype, was evaluated using centrifugation and filtration receptor binding techniques in rat brain crude synaptosomal membrane preparations. Maximal specific binding of [3H]AMPA occurred in Triton X-100 treated membranes in the presence of the chaotropic agent potassium thiocyanate (KSCN). The effects of KSCN on binding were reversible and optimal at 100 mM. Supernatant obtained from detergent-treated membranes inhibited specific [3H]AMPA and [3H]kainic acid binding, suggesting the presence of an inhibitory agent which was tentatively identified as glutamate. Using centrifugation, saturation analysis revealed two distinct binding sites in both the absence and presence of KSCN. The chaotrope was most effective in increasing binding at the low affinity binding site, enhancing the affinity (Kd) without a concommitant change in the total number of binding sites. Using filtration, a single binding site was detected in Triton-treated membranes. Like the data obtained by centrifugation, KSCN enhanced the affinity of the receptor (Kd value = 10 nM) without altering the number of binding sites (Bmax = 1.2 pmol/mg protein). The rank order of potency of various glutamate analogs in the [3H]AMPA binding assay was quisqualate greater than AMPA greater than L-glutamate greater than kainate greater than D-glutamate, consistent with the labeling of a quisqualate-type excitatory amino acid receptor subtype. L-glutamic acid diethylester, and 2-amino-7-phosphonoheptanoic acid (AP7) were inactive. The present technique provides a rapid, reliable assay for the evaluation of quisqualate-type excitatory amino acid agonists and/or antagonists that may be used to discover more potent and selective agents.
使用离心和过滤受体结合技术,在大鼠脑粗制突触体膜制剂中评估了[3H]AMPA(DL-α-氨基-3-羟基-5-甲基异恶唑-4-丙酸)(一种假定的喹啉酸兴奋性氨基酸受体亚型的配体)的结合情况。在离液剂硫氰酸钾(KSCN)存在下,[3H]AMPA的最大特异性结合发生在经Triton X-100处理的膜中。KSCN对结合的影响是可逆的,在100 mM时最为理想。从经去污剂处理的膜中获得的上清液抑制了特异性[3H]AMPA和[3H] kainic酸结合,表明存在一种抑制剂,初步鉴定为谷氨酸。使用离心法,饱和分析显示在不存在和存在KSCN的情况下均有两个不同的结合位点。离液剂在增加低亲和力结合位点的结合方面最有效,增强了亲和力(Kd),而结合位点总数没有相应变化。使用过滤法,在经Triton处理的膜中检测到一个单一的结合位点。与通过离心获得的数据一样,KSCN增强了受体的亲和力(Kd值 = 10 nM),而不改变结合位点的数量(Bmax = 1.2 pmol/mg蛋白质)。在[3H]AMPA结合试验中,各种谷氨酸类似物的效力顺序为喹啉酸大于AMPA大于L-谷氨酸大于海人藻酸大于D-谷氨酸,这与喹啉酸型兴奋性氨基酸受体亚型的标记一致。L-谷氨酸二乙酯和2-氨基-7-膦酰庚酸(AP7)无活性。本技术为评估喹啉酸型兴奋性氨基酸激动剂和/或拮抗剂提供了一种快速、可靠的检测方法,可用于发现更有效和更具选择性的药物。